N, A., E, B., J, C., S, D., M, D., D, D., . . . MC, V. (2026). Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients. Annals of hematology. https://doi.org/10.1007/s00277-026-07110-0
Chicago Style (17th ed.) CitationN, Albrecht, et al. "Multidisciplinary Approach to Managing GPRC5D-related Adverse Events in Relapsed or Refractory Multiple Myeloma Patients." Annals of Hematology 2026. https://doi.org/10.1007/s00277-026-07110-0.
MLA (9th ed.) CitationN, Albrecht, et al. "Multidisciplinary Approach to Managing GPRC5D-related Adverse Events in Relapsed or Refractory Multiple Myeloma Patients." Annals of Hematology, 2026, https://doi.org/10.1007/s00277-026-07110-0.
Warning: These citations may not always be 100% accurate.